Drug Delivery for Movement Disorders
Progress in Neurological Surgery
|January 15, 2018
Summary
Researchers are exploring direct brain drug delivery for Parkinson's Disease (PD) and movement disorders. This involves investigating neurotrophic factors like glial cell-line derived neurotrophic factor (GDNF) for therapeutic potential.
Area of Science:
- Neuroscience
- Pharmacology
- Neurology
Background:
- Parkinson's Disease (PD) and movement disorders are characterized by neurodegeneration.
- Current treatments offer symptomatic relief but do not halt disease progression.
- Neurotrophic factors show promise for neuroprotection and regeneration.
Purpose of the Study:
- To review past and present research on direct brain drug delivery for PD and movement disorders.
- To evaluate the potential of neurotrophic factors in treating these conditions.
- To discuss the challenges and future directions in this therapeutic area.
Main Methods:
- Review of pre-clinical studies and clinical trials involving direct neurotrophic factor delivery.
- Analysis of research on glial cell-line derived neurotrophic factor (GDNF) infusion.
- Synthesis of existing literature on brain drug delivery strategies for movement disorders.
Main Results:
- Direct infusion of GDNF has been investigated in PD models and human trials.
- Substantial research interest exists in delivering neurotrophic factors directly to the brain.
- The potential of direct drug delivery for PD treatment is under active investigation.
Conclusions:
- Direct brain drug delivery, particularly using neurotrophic factors, represents a promising therapeutic strategy for PD.
- Further research and clinical trials are needed to optimize delivery methods and assess long-term efficacy.
- Understanding the complexities of brain drug delivery is crucial for advancing treatment options for movement disorders.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.2K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
01:16Drug Delivery: Overview
937
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
937
01:18Drug Delivery: Enteral Route
1.9K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.9K
01:29Drug Delivery: Parenteral Route
1.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.8K
01:18Transdermal Drug Delivery Systems
23
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
23
01:23Ophthalmic Drug Delivery Systems
22
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
22